MedTrace Logo

Profitability Trial in Primary Preventive Implantable Cardioverter-defibrillator Recipients

NCT01823211 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-10-28

No results posted yet for this study

Summary

The purpose of this study is further risk stratification of patients receiving implantable cardioverter-defibrillator in primary prevention of sudden cardiac death.

Conditions

  • Ischaemic Cardiomyopathy
  • Non-ischaemic Cardiomyopathy

Sponsors & Collaborators

  • University Hospital Olomouc

    collaborator OTHER

  • Brno University Hospital

    collaborator OTHER

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Jiri Plasek, MD, PhD · Department of Cardiology,University hospital Ostrava

  • Milos Taborsky, MD, PhD, FESC · Department of Cardiology,University Hospital Olomouc

  • Lubos Krivan, MD, PhD · Department of Cardiology,University Hospital Brno-Bohunice

  • Ondrej Moravec, MD · Department of Cardiology,University Hospital Olomouc

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01823211 on ClinicalTrials.gov